<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig3">
 <label>Fig. 3</label>
 <caption>
  <title>Binding of inhibitors to SARS-CoV-2 M
   <sup>pro</sup> using thermal shift binding assay and native mass spectrometry.
  </title>
  <p>
   <bold>a</bold> Correlation of inhibition efficacy (IC
   <sub>50</sub>) with ΔT
   <sub>m</sub> from thermal shift binding assay. Data in Table 
   <xref rid="Tab2" ref-type="table">2</xref> were used for the plot. The r
   <sup>2</sup> of fitting is 0.94. 
   <bold>b</bold> Dose-dependent melting temperature (T
   <sub>m</sub>) shift. Native MS reveals binding of SARS-CoV-2 M
   <sup>pro</sup> to GC-376 (
   <bold>64</bold>) (
   <bold>c</bold>), calpain inhibitor II (
   <bold>61</bold>) (
   <bold>d</bold>), calpain inhibitor XII (
   <bold>62</bold>) (
   <bold>e</bold>), and boceprevir (
   <bold>28</bold>) (
   <bold>f</bold>). All ligand concentrations are 12.5 µM except (
   <bold>e</bold>), which is 25 µM. Peaks are annotated for dimer (blue circle), dimer with one bound ligand (yellow down triangle), and dimer with two bound ligands (red up triangle). Other minor signals are truncated dimers, which bind ligands at the same ratios. Charge states are annotated in 
   <bold>c</bold>, and insets show the deconvolved zero-charge mass distribution.
  </p>
 </caption>
 <graphic xlink:href="41422_2020_356_Fig3_HTML" id="d30e1208" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
